[Federal Register Volume 85, Number 89 (Thursday, May 7, 2020)]
[Notices]
[Page 27245]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-09706]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-628]


Bulk Manufacturer of Controlled Substances Application: Purisys, 
LLC

ACTION: Notice of application.

-----------------------------------------------------------------------

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may file written comments on or objections to 
the issuance of the proposed registration on or before July 6, 2020.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this 
is notice that on January 30, 2020, Purisys, LLC, 1550 Olympic Drive, 
Athens, Georgia 30601, applied to be registered as a bulk manufacturer 
of the following basic class(es) of controlled substances:

------------------------------------------------------------------------
         Controlled substance           Drug code         Schedule
------------------------------------------------------------------------
Amphetamine..........................        1100  II
Lisdexamfetamine.....................        1205  II
Cathinone............................        1235  I
Methylphenidate......................        1724  II
Morphine-N-Oxide.....................        9307  I
Normophine...........................        9313  I
Oripavine............................        9330  II
Thebaine.............................        9333  II
Opium Tincture.......................        9630  II
Oxymorphone..........................        9652  II
Noroxymorphone.......................        9668  II
Alfentanil...........................        9737  II
Sufentanil...........................        9740  II
Carfentanil..........................        9743  II
Tapentadol...........................        9780  II
Fentanyl.............................        9801  II
------------------------------------------------------------------------

    The company plans to manufacture the above-listed controlled 
substances to produce active pharmaceutical ingredients (API) for their 
prescription drug products and manufacture analytical reference 
standards for distribution to customers. The company also plans to use 
these substances for lab scale research and development activities.

William T. McDermott,
Assistant Administrator.
[FR Doc. 2020-09706 Filed 5-6-20; 8:45 am]
 BILLING CODE 4410-09-P